Analysis of the human serum proteome

[1]  T. Veenstra,et al.  Characterization of the Low Molecular Weight Human Serum Proteome*S , 2003, Molecular & Cellular Proteomics.

[2]  Ming Zhou,et al.  Cancer diagnosis using proteomic patterns , 2003, Expert review of molecular diagnostics.

[3]  Fang Wang,et al.  The human serum proteome: Display of nearly 3700 chromatographically separated protein spots on two‐dimensional electrophoresis gels and identification of 325 distinct proteins , 2003, Proteomics.

[4]  T. Veenstra,et al.  Development of a two-dimensional protein-peptide separation protocol for comprehensive proteome measurements. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[5]  R. Aebersold,et al.  Mass spectrometry-based proteomics , 2003, Nature.

[6]  Ignace Vergote,et al.  The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis. , 2003, Cancer research.

[7]  N. Anderson,et al.  The Human Plasma Proteome: History, Character, and Diagnostic Prospects , 2003, Molecular & Cellular Proteomics.

[8]  Ronald J. Moore,et al.  Toward a Human Blood Serum Proteome , 2002, Molecular & Cellular Proteomics.

[9]  E. Petricoin,et al.  Serum proteomic patterns for detection of prostate cancer. , 2002, Journal of the National Cancer Institute.

[10]  Sam S. Chang,et al.  The free/total prostate-specific antigen ratio (%fPSA) is the best predictor of tumor involvement in the radical prostatectomy specimen among men with an elevated PSA. , 2002, Urologic oncology.

[11]  D. Chan,et al.  Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. , 2002, Clinical chemistry.

[12]  P. Schellhammer,et al.  Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. , 2002, Cancer research.

[13]  G. Yousef,et al.  The new human tissue kallikrein gene family: structure, function, and association to disease. , 2001, Endocrine reviews.

[14]  J. Yates,et al.  Large-scale analysis of the yeast proteome by multidimensional protein identification technology , 2001, Nature Biotechnology.

[15]  G. Heinrich.  Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. , 1989, The New England journal of medicine.

[16]  E. Petricoin,et al.  Use of proteomic patterns in serum to identify ovarian cancer , 2002, The Lancet.